TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 43 - 2025

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Na
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 43 - 2025

Ipsen reported strong sales growth of 12.1% year-to-date and announced plans to acquire ImCheck Therapeutics to expand its oncology leadership, focusing on a clinical-stage program in acute myeloid leukemia.

Insights
DEO   neutral

Mentioned as a campaign sponsor with no specific context about their involvement


IPSEY   positive

Strong sales performance, strategic acquisition, and expansion of oncology pipeline indicate positive business momentum